AS

Ashok Sachdeva

Director Director DIN 05131627
DIN 05131627 First appointment Dec 2011 Primary industry E-Commerce
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Dec 2011
Shareholding value β€’β€’β€’β€’ Premium profile

About Ashok Sachdeva

Data last updated:

Ashok Sachdeva was a Director at Shree Shyam Mediways Private Limited (2011–2016) and Designated Partner at Global Biologics Llp (from 2015). The companies operate in E-Commerce.

DIN 05131627
Primary Designation Director
Industry E-Commerce
First Appointment 16 Dec 2011
Oldest Company Age 11 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shree Shyam Mediways Private Limited U51909DL2011PTC228900
Director16 Dec 20112011₹14.47 Cr (FY 2025)Active
Designated Partner13 Aug 20152015Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Global Biologics Llp
Shree Shyam Mediways Private Limited
Premium access

Shareholding and investment profile for Ashok Sachdeva

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ashok Sachdeva

Ashok Sachdeva was first appointed on 16 Dec 2011 as Director at Shree Shyam Mediways Private Limited. The most recent appointment on record is 13 Aug 2015 at Global Biologics Llp.

Ashok Sachdeva held 2 earlier board appointments: Shree Shyam Mediways Private Limited (Director, 16 Dec 2011 to 12 Jan 2016); Global Biologics Llp (Designated Partner, from 13 Aug 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available